Health Industry Critique
The discussion dives into the misleading nature of nutraceuticals and how they benefit corporate interests rather than public health. There's a critical examination of vaccine safety data, emphasizing that the information is already accessible, yet some still demand more. The conversation highlights the potential for regulatory changes that could complicate drug approval processes, ultimately questioning the motivations behind the push for less regulation in health care.In this clip
From this podcast
Maintenance Phase
BONUS: What's New With RFK Jr.?
Related Questions